Updated Jul 16, 2026
Anevski Peter has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $3.03M.

Peter Anevski is the Chief Executive Officer and a Director of Progyny, Inc., a company that specializes in fertility and women's health benefits solutions. He has been involved in the company's growth and development, contributing to its focus on providing comprehensive fertility benefits to employers.
| Role | CHIEF EXECUTIVE OFFICER, Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | PGNY | Progyny, Inc. | F — Tax withholding / forfeiture | 5.4K | $25.12 | $135K |
| 2026-03-04 | PGNY | Progyny, Inc. | F — Tax withholding / forfeiture | 17.6K | $17.60 | $310K |
| 2026-03-04 | PGNY | Progyny, Inc. | A — Grant or award | 159.1K | $0.00 | |
| 2025-10-01 | PGNY | Progyny, Inc. | F — Tax withholding / forfeiture | 8.0K | $21.52 | $172K |
| 2025-07-01 | PGNY | Progyny, Inc. | F — Tax withholding / forfeiture | 8.0K | $22.00 | $175K |
| 2024-12-26 | PGNY | Progyny, Inc. | P — Open-market purchase | 209.5K | $14.48 | $3.03M |
| 2024-10-03 | PGNY | Progyny, Inc. | F — Tax withholding / forfeiture | 8.0K | $16.76 | $134K |
Peter Anevski is the Chief Executive Officer and a Director of Progyny, Inc., a company that specializes in fertility and women's health benefits solutions. He has been involved in the company's growth and development, contributing to its focus on providing comprehensive fertility benefits to employers.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($3.03M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Anevski Peter profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.